Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: An upstream enhancer regulates Gpihbp1 expression in a tissue-specific manner.

Authors: Allan, Christopher M; Heizer, Patrick J; Tu, Yiping; Sandoval, Norma P; Jung, Rachel S; Morales, Jazmin E; Sajti, Eniko; Troutman, Ty D; Saunders, Thomas L; Cusanovich, Darren A; Beigneux, Anne P; Romanoski, Casey E; Fong, Loren G; Young, Stephen G

Published In J Lipid Res, (2019 Apr)

Abstract: Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1), the protein that shuttles LPL to the capillary lumen, is essential for plasma triglyceride metabolism. When GPIHBP1 is absent, LPL remains stranded within the interstitial spaces and plasma triglyceride hydrolysis is impaired, resulting in severe hypertriglyceridemia. While the functions of GPIHBP1 in intravascular lipolysis are reasonably well understood, no one has yet identified DNA sequences regulating GPIHBP1 expression. In the current studies, we identified an enhancer element located ∼3.6 kb upstream from exon 1 of mouse Gpihbp1. To examine the importance of the enhancer, we used CRISPR/Cas9 genome editing to create mice lacking the enhancer (Gpihbp1Enh/Enh). Removing the enhancer reduced Gpihbp1 expression by >90% in the liver and by ∼50% in heart and brown adipose tissue. The reduced expression of GPIHBP1 was insufficient to prevent LPL from reaching the capillary lumen, and it did not lead to hypertriglyceridemia-even when mice were fed a high-fat diet. Compound heterozygotes (Gpihbp1Enh/- mice) displayed further reductions in Gpihbp1 expression and exhibited partial mislocalization of LPL (increased amounts of LPL within the interstitial spaces of the heart), but the plasma triglyceride levels were not perturbed. The enhancer element that we identified represents the first insight into DNA sequences controlling Gpihbp1 expression.

PubMed ID: 30598475 Exiting the NIEHS site

MeSH Terms: Adipose Tissue, Brown/metabolism*; Animals; CRISPR-Cas Systems/genetics; Chromatin/genetics; Heart; Humans; Lipoprotein Lipase/metabolism*; Mice; Mice, Inbred Strains; Receptors, Lipoprotein/analysis; Receptors, Lipoprotein/genetics*; Receptors, Lipoprotein/metabolism; Sequence Analysis, DNA; Triglycerides/blood; Triglycerides/metabolism

Back
to Top